Form 4 for MTNB Matinas BioPharma Holdings, Inc.
Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-30 · accession 0001493152-21-015878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | 2021-06-30 | MTNB | WIKLER MATTHEW | Dir | A - Grant | $0.00 | +10.2K | 276.5K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | A | A | 10,244 | $0.00 | 276,507 | D | — | — | (F1) On June 30, 2021, the Reporting Person was issued 10,244 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant. |